Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Holtkamp FA, de Zeeuw D, de Graeff PA, Laverman GD, Berl T, Remuzzi G, Packham D, Lewis JB, Parving HH, Lambers Heerspink HJ (2011) Eur Heart J 32: 1493-9 A diabetes-predictive amino acid score and future cardiovascular disease. Magnusson M, Lewis GD, Ericson U, Orho-Melander M, Hedblad B, Engström G, Ostling G, Clish C, Wang TJ, Gerszten RE, Melander O (2013) Eur Heart J 34: 1982-9 Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. Yang EH, Gumina RJ, Lennon RJ, Holmes DR, Rihal CS, Singh M (2005) J Am Coll Cardiol 46: 2004-9 Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Paueksakon P, Revelo MP, Ma LJ, Marcantoni C, Fogo AB (2002) Kidney Int 61: 2142-8 Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD (2006) Diabetes 55: 1985-94 Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study. Reis JP, Allen NB, Bancks MP, Carr JJ, Lewis CE, Lima JA, Rana JS, Gidding SS, Schreiner PJ (2018) Diabetes Care 41: 731-738 Contributors to mortality in high-risk diabetic patients in the Diabetes Heart Study. Cox AJ, Hsu FC, Freedman BI, Herrington DM, Criqui MH, Carr JJ, Bowden DW (2014) Diabetes Care 37: 2798-803 Spectrum of autonomic cardiovascular neuropathy in diabetes. Jacob G, Costa F, Biaggioni I (2003) Diabetes Care 26: 2174-80 The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Freedman BI, Hsu FC, Langefeld CD, Rich SS, Herrington DM, Carr JJ, Xu J, Bowden DW, Wagenknecht LE (2005) Diabetologia 48: 2511-8 Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study. Register TC, Divers J, Bowden DW, Carr JJ, Lenchik L, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Hruska KA, Langefeld CD, Freedman BI (2013) J Clin Endocrinol Metab 98: 1916-22 Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study. Divers J, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Register TC, Xu J, Langefeld CD, Freedman BI (2010) J Clin Endocrinol Metab 95: 5382-9 Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. Lehtinen AB, Burdon KP, Lewis JP, Langefeld CD, Ziegler JT, Rich SS, Register TC, Carr JJ, Freedman BI, Bowden DW (2007) J Clin Endocrinol Metab 92: 345-52 Microalbuminuria as a target to improve cardiovascular and renal outcomes. Basi S, Lewis JB (2006) Am J Kidney Dis 47: 927-46 Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Niswender K (2010) Diabetes Obes Metab 12: 267-87 Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure. Smith HM, Hamblin M, Hill MF (2005) J Mol Cell Cardiol 39: 657-65 A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP (2005) Am J Med 118: 276-84 Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study. Cox AJ, Lehtinen AB, Xu J, Langefeld CD, Freedman BI, Carr JJ, Bowden DW (2013) Acta Diabetol 50: 391-9 Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Carr JJ, Rich SS, Freedman BI, Herrington D, Bowden DW (2006) Am Heart J 151: 706-11 Nonpharmacologic treatment of dyslipidemia. Houston MC, Fazio S, Chilton FH, Wise DE, Jones KB, Barringer TA, Bramlet DA (2009) Prog Cardiovasc Dis 52: 61-94 Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia. Ali YS, Linton MF, Fazio S (2008) Curr Opin Endocrinol Diabetes Obes 15: 142-6 Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Ramanathan V, Goral S, Tanriover B, Feurer ID, Kazancioglu R, Shaffer D, Helderman JH (2005) Transplantation 79: 1453-8 C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study. Cox AJ, Agarwal S, M Herrington D, Carr JJ, Freedman BI, Bowden DW (2012) Diabet Med 29: 767-70 Association analysis of genes in the renin-angiotensin system with subclinical cardiovascular disease in families with Type 2 diabetes mellitus: the Diabetes Heart Study. Burdon KP, Langefeld CD, Wagenknecht LE, Carr JJ, Freedman BI, Herrington D, Bowden DW (2006) Diabet Med 23: 228-34 Kidney volume associations with subclinical renal and cardiovascular disease: the Diabetes Heart Study. Saran AM, Hsu FC, Lohman KK, Carr JJ, Bowden DW, Wagenknecht LE, Freedman BI (2008) Am J Nephrol 28: 366-71 Analysis of advanced glycation end products in the DHS Mind Study. Adams JN, Martelle SE, Raffield LM, Freedman BI, Langefeld CD, Hsu FC, Maldjian JA, Williamson JD, Hugenschmidt CE, Carr JJ, Cox AJ, Bowden DW (2016) J Diabetes Complications 30: 262-8 The revolution in risk assessment and disease detection made possible with non-invasive imaging: implications for population science. Carr JJ (2012) Ethn Dis 22: S1-24-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.